BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750
47 results:

  • 1. Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma.
    Grieve C; Joseph A; Drullinsky P; Zelenetz AD; Hamlin P; Kumar A
    Leuk Lymphoma; 2024 Feb; 65(2):235-241. PubMed ID: 38264906
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in cancer Development and Therapeutic Potential.
    Dinh NTM; Nguyen TM; Park MK; Lee CH
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255791
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
    de Vos-Hillebrand L; Fietz S; Hillebrand P; Kulcsár Z; Diop MY; Hollick S; Maas AP; Strieth S; Landsberg J; Dietrich D
    Pigment Cell Melanoma Res; 2024 Mar; 37(2):309-315. PubMed ID: 37975535
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancer.
    Zhou J; Xie T; Shan H; Cheng G
    Radiat Oncol; 2023 Jul; 18(1):117. PubMed ID: 37434241
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer.
    Feng Z; Zuo K; Ju X; Chen X; Yang W; Wen H; Yu L; Wu X
    J Ovarian Res; 2023 Jun; 16(1):125. PubMed ID: 37386498
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Surviving the COVID-19 pandemic: navigating the recovery of breast imaging services in a safety-net hospital.
    Porembka JH; Seiler SJ; Ozcan BB; Evans WP; Tiro J; Dogan BE
    Breast Cancer Res Treat; 2023 Aug; 201(1):127-138. PubMed ID: 37330947
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand.
    Lucas E; Murillo R; Arrossi S; Bárcena M; Chami Y; Nessa A; Perera S; Silva P; Sangrajrang S; Muwonge R; Basu P
    Elife; 2023 May; 12():. PubMed ID: 37191660
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany.
    van der Ven J; Linz VC; Anic K; Schmidt MW; Loewe A; Krajnak S; Schmidt M; Kommoss S; Schmalfeldt B; Sehouli J; Hasenburg A; Battista MJ
    Arch Gynecol Obstet; 2023 Aug; 308(2):527-534. PubMed ID: 36707423
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construct Validity of the Steep ramp Test for Assessing Cardiorespiratory Fitness in Patients With breast cancer and the Effect of Chemotherapy-Related Symptom Burden.
    de Wiel HJV; Groen WG; Kampshoff CS; Buffart LM; van Mechelen W; Schep G; Sonke GS; Huijsmans R; van Harten WH; Aaronson NK; Stuiver MM
    Arch Phys Med Rehabil; 2022 Dec; 103(12):2362-2367. PubMed ID: 35732249
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An Observational and Cross-Sectional Study of the Prevalence of breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China.
    Li S; Xu Z; Li H; Tang J; Liang XY; Tian S; Wu J; Li X; Liu ZL; Xiao J; Chen YL; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):31-39. PubMed ID: 35306559
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Viscoelastic parameters of invasive breast cancer in correlation with porous structure and elemental analysis data.
    Mojra A; Hooman K
    Comput Methods Programs Biomed; 2021 Nov; 212():106482. PubMed ID: 34736165
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.
    Nomura H; Ikki A; Fusegi A; Omi M; Aoki Y; Netsu S; Tanigawa T; Matoda M; Okamoto S; Omatsu K; Nakajima T; Ueki A; Tonooka A; Kanao H
    Int J Clin Oncol; 2021 Dec; 26(12):2331-2337. PubMed ID: 34453642
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
    Zirimwabagabo JO; Jailani ABA; Avgoustou P; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Wang N; Skerry TM; Richards GO; Harrity JPA
    J Med Chem; 2021 Mar; 64(6):3299-3319. PubMed ID: 33666424
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Repeatability of Linear and Nonlinear Elastic Modulus Maps From Repeat Scans in the breast.
    Gendin DI; Nayak R; Wang Y; Bayat M; Fazzio RT; Oberai AA; Hall TJ; Barbone PE; Alizad A; Fatemi M
    IEEE Trans Med Imaging; 2021 Feb; 40(2):748-757. PubMed ID: 33151880
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi-parameter Sub-Hertz Analysis of Viscoelasticity With a Quality Metric for Differentiation of breast Masses.
    Bayat M; Nabavizadeh A; Nayak R; Webb JM; Gregory AV; Meixner DD; Fazzio RT; Insana MF; Alizad A; Fatemi M
    Ultrasound Med Biol; 2020 Dec; 46(12):3393-3403. PubMed ID: 32917470
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [The pathology of hereditary ovarian tumors].
    Pesce F; Devouassoux-Shisheboran M
    Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Kinetic Analysis of Lesions Identified on a Rapid Abridged Multiphase (ramp) breast MRI Protocol.
    Choudhery S; Chou SS; Chang K; Kalpathy-Cramer J; Lehman CD
    Acad Radiol; 2020 May; 27(5):672-681. PubMed ID: 31147233
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of human observer performance on lesion detectability in single-slice and multislice dedicated breast cone beam CT images with breast anatomical background.
    Han M; Jang H; Baek J
    Med Phys; 2018 Dec; 45(12):5385-5396. PubMed ID: 30273955
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Automated In Vivo Sub-Hertz Analysis of Viscoelasticity (SAVE) for Evaluation of breast Lesions.
    Bayat M; Nabavizadeh A; Kumar V; Gregory A; Insana M; Alizad A; Fatemi M
    IEEE Trans Biomed Eng; 2018 Oct; 65(10):2237-2247. PubMed ID: 29989938
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
    Minig L; Cabrera S; Oliver R; Couso A; Rubio MJ; Iacoponi S; Martin-Salamanca MB; Carballo-Rastrilla S; Cádenas-Rebollo JM; García-Garcia A; Gil-Ibáñez B; Juan-Fita MJ; Patrono MG
    Clin Transl Oncol; 2018 Oct; 20(10):1337-1344. PubMed ID: 29623583
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.